| Is it Worth Retaining Boston Scientific Stock in Your Portfolio Now? |
Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and strategic acquisitions. |
zacks.com |
2025-05-14 12:15:43 |
Czytaj oryginał (ang.) |
| Boston Scientific Corporation (BSX) Bank of America's 2025 Health Care Conference (Transcript) |
Boston Scientific Corporation (NYSE:BSX ) Bank of America's 2025 Health Care Conference May 13, 2025 11:00 AM ET Company Participants Daniel Brennan - EVP & CFO Joe Fitzgerald - EVP & Group President, Cardiology Conference Call Participants Travis Steed - Bank of America Travis Steed All right. Good morning, everybody. |
seekingalpha.com |
2025-05-13 19:33:47 |
Czytaj oryginał (ang.) |
| PAHC or BSX: Which Is the Better Value Stock Right Now? |
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2025-05-12 16:46:03 |
Czytaj oryginał (ang.) |
| Here is What to Know Beyond Why Boston Scientific Corporation (BSX) is a Trending Stock |
Zacks.com users have recently been watching Boston Scientific (BSX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects. |
zacks.com |
2025-05-08 14:00:55 |
Czytaj oryginał (ang.) |
| Boston Scientific Stock Flirts With A Buy Point, Once Again |
Boston Scientific stock is wavering around the buy point of a double-bottom base. The company recently raised its 2025 earnings outlook. |
investors.com |
2025-05-07 18:06:06 |
Czytaj oryginał (ang.) |
| MedTechs Adjust 2025 Outlook Amid Tariffs: What Investors Need to Know |
Most of the MedTech players have adjusted their 2025 forecasts in response to rising tariff pressure. |
zacks.com |
2025-05-05 20:00:40 |
Czytaj oryginał (ang.) |
| These 3 Stocks Soared Following Strong Quarterly Results |
The 2025 Q1 earnings cycle is in full swing. And these three companies posted results that had investors pleased. |
zacks.com |
2025-05-01 21:51:08 |
Czytaj oryginał (ang.) |
| Boston Scientific announces upcoming investor conference schedule |
MARLBOROUGH, Mass. , May 1, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May. |
prnewswire.com |
2025-05-01 12:00:00 |
Czytaj oryginał (ang.) |
| Earnings Season: 3 Companies Raising Guidance |
Raising guidance? In this uncertainty? |
zacks.com |
2025-04-29 16:15:40 |
Czytaj oryginał (ang.) |
| Baron Health Care Fund Q1 2025 Top Contributors And Detractors |
Boston Scientific's shares rose due to strong market growth, innovative products like pulsed field ablation, and disciplined cost management, driving double-digit EPS growth. Vertex Pharmaceuticals saw increased investor confidence in its cystic fibrosis franchise and evolving pipeline, including promising non-opioid pain treatments and kidney disease drugs. UnitedHealth Group's shares gained as 2024 headwinds subsided, Medicare Advantage rates improved, and higher-margin Optum segments grew, insulating it from tariff impacts. |
seekingalpha.com |
2025-04-29 15:30:00 |
Czytaj oryginał (ang.) |
| EMEA Growth & Product Launches to Support Boston Scientific Stock |
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States. |
zacks.com |
2025-04-28 18:30:39 |
Czytaj oryginał (ang.) |
| Wall Street Analysts Think Boston Scientific (BSX) Is a Good Investment: Is It? |
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter? |
zacks.com |
2025-04-28 14:30:54 |
Czytaj oryginał (ang.) |
| MercadoLibre, The Amazon Of Latin America, Leads Five Stocks Near Buy Points |
Stocks near buy points include Charles Schwab, German software leader SAP and MercadoLibre, the so-called Amazon of Latin America, |
investors.com |
2025-04-26 12:00:43 |
Czytaj oryginał (ang.) |
| Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now |
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials. |
zacks.com |
2025-04-25 17:45:34 |
Czytaj oryginał (ang.) |
| Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know |
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). |
zacks.com |
2025-04-25 17:00:35 |
Czytaj oryginał (ang.) |
| Here's Why Boston Scientific (BSX) is a Strong Momentum Stock |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-04-25 14:50:41 |
Czytaj oryginał (ang.) |
| Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? |
Here is how Boston Scientific (BSX) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year. |
zacks.com |
2025-04-25 14:46:12 |
Czytaj oryginał (ang.) |
| Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints |
Trial achieves positive results in the treatment of persistent atrial fibrillation MARLBOROUGH, Mass. and SAN DIEGO , April 24, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month primary endpoint results from the second phase of the ADVANTAGE AF clinical trial evaluating the use of the FARAPULSE™ Pulsed Field Ablation (PFA) System* and adjunctive use of the FARAPOINT™ PFA Catheter in patients with persistent atrial fibrillation (AF). |
prnewswire.com |
2025-04-24 19:41:00 |
Czytaj oryginał (ang.) |
| Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results |
Boston Scientific Corporation BSX posted better-than-expected earnings for the first quarter on Wednesday. |
benzinga.com |
2025-04-24 18:13:09 |
Czytaj oryginał (ang.) |
| Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-04-24 14:45:39 |
Czytaj oryginał (ang.) |
| Boston Scientific announces completion of €1.5 billion offering of senior notes |
MARLBOROUGH, Mass. , Feb. 26, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V. |
prnewswire.com |
2025-02-26 18:15:00 |
Czytaj oryginał (ang.) |
| Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System |
Dublin, Feb. 24, 2025 (GLOBE NEWSWIRE) -- The "Balloon Catheters Patent Landscape Report" has been added to ResearchAndMarkets.com's offering. |
globenewswire.com |
2025-02-24 13:50:00 |
Czytaj oryginał (ang.) |
| Is Boston Scientific (BSX) Outperforming Other Medical Stocks This Year? |
Here is how Boston Scientific (BSX) and Abivax SA Sponsored ADR (ABVX) have performed compared to their sector so far this year. |
zacks.com |
2025-02-24 12:40:25 |
Czytaj oryginał (ang.) |
| Boston Scientific announces pricing of €1.5 billion of senior notes |
MARLBOROUGH, Mass. , Feb. 21, 2025 /PRNewswire/ -- Boston Scientific Corporation (the "Company") (NYSE: BSX) today announced that American Medical Systems Europe B.V. |
prnewswire.com |
2025-02-21 23:35:00 |
Czytaj oryginał (ang.) |
| Boston Scientific Expects Strong Gains in 2025: Time to Buy the Stock? |
Boston Scientific begins 2025 on a solid note, expecting organic revenue growth of 14% to 16% in the first quarter. |
zacks.com |
2025-02-20 14:51:16 |
Czytaj oryginał (ang.) |
| Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference |
MARLBOROUGH, Mass. , Feb. 19, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in TD Cowen's 45th Annual Health Care Conference on Tuesday, March 4, 2025. |
prnewswire.com |
2025-02-19 10:00:00 |
Czytaj oryginał (ang.) |
| PBH or BSX: Which Is the Better Value Stock Right Now? |
Investors interested in Medical - Products stocks are likely familiar with Prestige Consumer Healthcare (PBH) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks? |
zacks.com |
2025-02-17 14:46:17 |
Czytaj oryginał (ang.) |
| EMEA Expansion to Support BSX Stock Amid Fierce Competition |
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States. |
zacks.com |
2025-02-12 14:41:30 |
Czytaj oryginał (ang.) |
| 5 Top-Ranked Efficient Stocks to Buy for Solid Gains Amid Volatility |
Invest in stocks of EAT, BFST, AZEK, CLS and BSX to tap their high efficiency levels. |
zacks.com |
2025-02-12 10:11:13 |
Czytaj oryginał (ang.) |
| What's Behind The 130% Rise In BSX Stock? |
Boston Scientific stock (NYSE: BSX) has gained 3% in the five days since its Q4 earnings report last week. Although the company exceeded expectations with both its results and guidance, the modest stock increase may be due to the significant price appreciation ahead of the earnings announcement. |
forbes.com |
2025-02-12 09:00:11 |
Czytaj oryginał (ang.) |
| The Zacks Analyst Blog The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific |
The Procter & Gamble, Boston, ConocoPhillips and Kewaunee Scientific are included in this Analyst Blog. |
zacks.com |
2025-02-11 07:46:18 |
Czytaj oryginał (ang.) |
| Best Momentum Stocks to Buy for February 10th |
BSX, ENVA and CFR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 10, 2025. |
zacks.com |
2025-02-10 13:01:20 |
Czytaj oryginał (ang.) |
| 5 Momentum Stocks to Buy for February Amid Volatility |
These five stocks have strong momentum for February. These are: APH, BSX, NLY, PNFP, FHN. |
zacks.com |
2025-02-10 11:05:23 |
Czytaj oryginał (ang.) |
| New Strong Buy Stocks for February 10th |
PFIS, BSX, ENVA, NFG and NLY have been added to the Zacks Rank #1 (Strong Buy) List on February 10, 2025. |
zacks.com |
2025-02-10 08:51:15 |
Czytaj oryginał (ang.) |
| Boston Scientific (BSX) is a Great Momentum Stock: Should You Buy? |
Does Boston Scientific (BSX) have what it takes to be a top stock pick for momentum investors? Let's find out. |
zacks.com |
2025-02-07 15:01:19 |
Czytaj oryginał (ang.) |
| Has Boston Scientific (BSX) Outpaced Other Medical Stocks This Year? |
Here is how Boston Scientific (BSX) and Alphatec (ATEC) have performed compared to their sector so far this year. |
zacks.com |
2025-02-07 12:46:31 |
Czytaj oryginał (ang.) |
| Here's Why Boston Scientific (BSX) is a Strong Growth Stock |
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores. |
zacks.com |
2025-02-06 12:46:21 |
Czytaj oryginał (ang.) |
| Boston Scientific Corporation (BSX) Q4 2024 Earnings Call Transcript |
Boston Scientific Corporation (NYSE:BSX ) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Company Participants Jonathan Monson - SVP, IR Michael Mahoney - Chairman and CEO Daniel Brennan - EVP and CFO Kenneth Stein - Chief Medical Officer Conference Call Participants Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Frederick Wise - Stifel Joanne Wuensch - Citibank David Roman - Goldman Sachs Travis Steed - Bank of America Patrick Wood - Morgan Stanley Danielle Antalffy - UBS Michael Polark - Wolfe Research Vijay Kumar - Evercore ISI Pito Chickering - Deutsche Bank Joshua Jennings - TD Cowen Chris Pasquale - Nephron Research Operator Good morning, and welcome to the Boston Scientific Fourth Quarter 2024 Earnings Call. All participants will be listen-only mode. |
seekingalpha.com |
2025-02-05 13:31:45 |
Czytaj oryginał (ang.) |
| Boston Scientific (BSX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates |
The headline numbers for Boston Scientific (BSX) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
zacks.com |
2025-02-05 12:36:28 |
Czytaj oryginał (ang.) |
| BSX Q4 Earnings & Revenues Top, Stock Falls on Weak Gross Margin |
Boston Scientific's fourth-quarter 2024 performance reflects the strength of its core franchises. |
zacks.com |
2025-02-05 12:15:33 |
Czytaj oryginał (ang.) |
| 5 Non-Tech Outperformers of 2024 Set to Fly Higher in the Near Term |
Five non-technology high-flyers of 2024 have the potential to fly higher in the short term. These are: CMG, IBKR, KKR, FI, BSX. |
zacks.com |
2025-01-03 11:15:28 |
Czytaj oryginał (ang.) |
| Boston Scientific Announces Participation in the J.P. Morgan Healthcare Conference and Conference Call Discussing Fourth Quarter 2024 Results |
MARLBOROUGH, Mass. , Jan. 2, 2025 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will participate in the 43rd Annual J.P. |
prnewswire.com |
2025-01-02 10:00:00 |
Czytaj oryginał (ang.) |
| Is Boston Scientific Stock a Smart Pick for Your Portfolio Right Now? |
Investors continue to be optimistic about BSX, courtesy of its international expansion efforts and WATCHMAN's performance. |
zacks.com |
2025-01-02 09:41:27 |
Czytaj oryginał (ang.) |
| Why Boston Scientific (BSX) is Poised to Beat Earnings Estimates Again |
Boston Scientific (BSX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. |
zacks.com |
2025-01-01 15:15:31 |
Czytaj oryginał (ang.) |
| Boston Scientific Corporation: Solid Financials And Upward Continuation |
Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. The smooth upward movement of the stock indicates the quality of its investor base. Strong profit margins and robust growth expectations for the short-term future make me overlook its high valuation. |
seekingalpha.com |
2024-12-31 10:55:11 |
Czytaj oryginał (ang.) |
| Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know |
In the closing of the recent trading day, Boston Scientific (BSX) stood at $89.68, denoting a -1.08% change from the preceding trading day. |
zacks.com |
2024-12-30 21:21:41 |
Czytaj oryginał (ang.) |
| PBH vs. BSX: Which Stock Is the Better Value Option? |
Investors looking for stocks in the Medical - Products sector might want to consider either Prestige Consumer Healthcare (PBH) or Boston Scientific (BSX). But which of these two stocks presents investors with the better value opportunity right now? |
zacks.com |
2024-12-30 14:41:20 |
Czytaj oryginał (ang.) |
| 5 MedTech Stocks That Are Poised to Beat the Market in 2025 |
Here, we discuss five stocks that are likely to generate better than the market, driven by strong demand for existing products and the addition of innovative new devices. |
zacks.com |
2024-12-30 12:01:38 |
Czytaj oryginał (ang.) |
| 5 Top AI-in-MedTech Stocks for Big Gains in 2025: MDT, BSX & More |
Here we discuss five medical stocks - MDT, BSX, BDX, GEHC and TEM - incorporating AI in their workflows. These are likely to gain in 2025 as AI helps cut costs and improve patient care. |
zacks.com |
2024-12-30 10:31:10 |
Czytaj oryginał (ang.) |
| S&P 500 Winners Fortinet, Boston Scientific Lead 5 Stocks Near Buy Points |
S&P 500 components Fortinet and Boston Scientific are among five stocks to watch near buy points as 2024 comes to a close. The post S&P 500 Winners Fortinet, Boston Scientific Lead 5 Stocks Near Buy Points appeared first on Investor's Business Daily. |
investors.com |
2024-12-28 10:00:49 |
Czytaj oryginał (ang.) |
| Why Boston Scientific (BSX) Outpaced the Stock Market Today |
In the most recent trading session, Boston Scientific (BSX) closed at $91.07, indicating a +1.35% shift from the previous trading day. |
zacks.com |
2024-12-24 21:00:44 |
Czytaj oryginał (ang.) |
| 4 Healthcare Stocks Rising More Than 50% in 2024 With Room to Grow |
Medical stocks are expected to reap the benefits of affordable health insurance plans, rising surgeries and widespread adoption of telehealth services in the days ahead. However, inflation and supply-chain woes may act as spoilsport. |
zacks.com |
2024-12-24 12:11:11 |
Czytaj oryginał (ang.) |
| Boston Scientific (BSX) Rises Higher Than Market: Key Facts |
Boston Scientific (BSX) reachead $89.86 at the closing of the latest trading day, reflecting a +1.02% change compared to its last close. |
zacks.com |
2024-12-23 21:21:34 |
Czytaj oryginał (ang.) |
| All You Need to Know About Boston Scientific (BSX) Rating Upgrade to Buy |
Boston Scientific (BSX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy). |
zacks.com |
2024-12-19 15:00:28 |
Czytaj oryginał (ang.) |
| FDA classifies recall of Boston Scientific catheters as 'most serious' |
The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's catheters used in a type of minimally invasive surgery as "most serious". |
reuters.com |
2024-12-18 18:16:16 |
Czytaj oryginał (ang.) |
| BSX Trades Near 52-Week High: Does the Stock Hold More Potential? |
We believe Boston Scientific is one of those MedTech manufacturers that can be considered as the biggest gainers from the Fed's two successive interest rate cuts in 2024. |
zacks.com |
2024-12-18 13:56:13 |
Czytaj oryginał (ang.) |
| Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? |
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important? |
zacks.com |
2024-12-13 12:30:39 |
Czytaj oryginał (ang.) |
| Innovations and Buyouts Support BSX Stock Amid Macroeconomic Woes |
Boston Scientific successfully continues with its expansion of operations across different geographies outside the United States. |
zacks.com |
2024-12-12 12:31:36 |
Czytaj oryginał (ang.) |
| Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note |
Boston Scientific (BSX) closed the most recent trading day at $90.56, moving +0.4% from the previous trading session. |
zacks.com |
2024-12-11 21:01:26 |
Czytaj oryginał (ang.) |
| Boston Scientific CMO Discuss Solutions for Health Inequality on Today's Marketplace |
NEW YORK , Dec. 11, 2024 /PRNewswire/ -- Today's Marketplace (TMP) is proud to announce a featured interview with Boston Scientific (NYSE: BSX) Global Chief Medical Officer, Kenneth Stein, MD, and Scott Shipman, MD, MPH, Executive Director for the Institute for Population Health. The doctors joined host Jane King to discuss health inequities and Boston Scientific's work to improve access to care for underserved populations. |
prnewswire.com |
2024-12-11 10:08:00 |
Czytaj oryginał (ang.) |